Not applicableStudy completedNCT03321916What this trial is testingMacTel Laser StudyWho this might be right forMacular Telangiectasia The Lowy Medical Research Institute Limited 9
Large-scale testing (Phase 3)Not Yet RecruitingNCT07342439What this trial is testingStudy of Serine Supplementation to Protect Vision in MacTelWho this might be right forMacular Telangiectasia Type 2 (MacTel) The Lowy Medical Research Institute Limited 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04907084What this trial is testingSerine and Fenofibrate Study in Patients With MacTel Type 2Who this might be right forMacular Telangiectasia Type 2 The Lowy Medical Research Institute Limited 60
Testing effectiveness (Phase 2)Study completedNCT03669393What this trial is testingEvaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)Who this might be right forRetinal TelangiectasisIdiopathic Juxtafoveal Retinal Telangiectasia ThromboGenics 8
Large-scale testing (Phase 3)Study completedNCT03316300What this trial is testingDetermine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AWho this might be right forMacular Telangiectasia Type 2 (MacTel) Neurotech Pharmaceuticals 120
Post-approval studies (Phase 4)Looking for participantsNCT06971939What this trial is testingPhase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure ParticipantsWho this might be right forMacular Telangiectasia Type 2 (MacTel) Neurotech Pharmaceuticals 285
Large-scale testing (Phase 3)Active Not RecruitingNCT06397131What this trial is testingDetermine the Safety and Efficacy of NT-501 With MHFMWho this might be right forMacular Telangiectasia Type 2 Neurotech Pharmaceuticals 12
Not applicableStudy completedNCT01354093What this trial is testingThe Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)Who this might be right forIdiopathic Juxtafoveal Telangiectasia Paul S. Bernstein 8
Testing effectiveness (Phase 2)Study completedNCT04729972What this trial is testingSafety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2Who this might be right forMacular Telangiectasia Type 2 Neurotech Pharmaceuticals 33
Early research (Phase 1)Study completedNCT01327911What this trial is testingCiliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)Who this might be right forIdiopathic Juxtafoveal Telangiectasia Neurotech Pharmaceuticals 7
Testing effectiveness (Phase 2)Study completedNCT03071965What this trial is testingExtension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)Who this might be right forMacTel (Macular Telangiectasia) Type 2 Neurotech Pharmaceuticals 70
Large-scale testing (Phase 3)Study completedNCT03319849What this trial is testingDetermine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol BWho this might be right forMacular Telangiectasia Type 2 Neurotech Pharmaceuticals 119
Testing effectiveness (Phase 2)Study completedNCT01949324What this trial is testingMulticenter Randomized Clinical Trial of CNTF for MacTelWho this might be right forMacular Telangiectasia Type 2 Neurotech Pharmaceuticals 67